11 February 2021 - new contract/trading update
We last recommended shares in AIM-listed Omega Diagnostics back in December at 56.5p and so it is very pleasing to see that the share price has almost doubled in just over two months! Today's news that the company has won a contract from the Government to provide COVID-19 lateral flow antigen tests is clearly a big positive for the share price. Apart from its own manufacturing capacity, the Government is set to loan the company additional manufacturing equipment and this should mean that Omega has the capability to provide . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.